Story Poster
Georgia Football

ESPN: UGA Football Commit Dylan Raiola No Longer No. 1 Prospect

June 29, 2023

Real Georgia Fans Don’t Miss the Dawg Post Newsletter - Sign up now!

ATHENS - 5-star QB and UGA football commit Dylan Raiola No Longer No. 1 Prospect is no longer the No. 1 prospect, ESPN said on Thursday

“While Dylan Raiola, the previous No. 1 overall recruit in this cycle, is a Heisman-caliber quarterback in a very strong QB class, we are convinced that this class has an elite shutdown corner,” ESPN’s report said. 

That corner? None other than UGA football commit Ellis Robinson IV‍, who is at IMG in Florida having grown up in Connecticut. Georgia has the consensus No. 1 class in 2024. Insiders have indicated to Dawg Post that the Bulldogs should expect another commitment to the growing class next week. 

2023 Dawg Post Preview Included Free with Double Dawgs

Reserve Your Copy of DOUBLE DAWGS NOW!

ESPN goes on to say this of Raiola: 

“Robinson's rise from No. 4 to No. 1 is more a reflection of his ability and overall grade as agreed upon by our scouts rather than Raiola falling short. To be clear, Raiola, also a Georgia commit, moves down to No. 2 overall not because of his play or Elite 11 performance, which was quite strong. The top two competitors at Elite 11 were Raiola and new No. 3 prospect Julian Sayin,” the article said. 

Why did Robinson leap Raiola?

“The Georgia commit has elite tools at a premium position with a zero-to-low bust factor. Robinson can run, cover and hit as well as any corner we have seen in recent years. The level of competition he faces at IMG Academy -- he regularly works against the nation's top wideouts in practice and throughout the season -- should better prepare him for contributing quickly once he arrives on campus.”

UGA football WR commit NiTareon Tuggle jumped into ESPN’s Top 300 rankings and landed at No. 162. 

Shirts Are in Stock Now!


Check this deal out today!



subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.